Pacific Biosciences of California PACB Shares (Diluted)
Discontinued — last reported Q1 '26
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's shares (diluted)?
- Pacific Biosciences of California (PACB) reported shares (diluted) of 305.8M in Q1 2026.
- How has Pacific Biosciences of California's shares (diluted) changed year-over-year?
- Pacific Biosciences of California's shares (diluted) increased by 3.0% year-over-year, from 296.9M to 305.8M.
- What is the long-term trend for Pacific Biosciences of California's shares (diluted)?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's shares (diluted) has grown at a 10.2% compound annual growth rate (CAGR), from 812.6M to 1.2B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.